Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
2.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 39(4): 309-315, Oct.-Dec. 2017. tab
Article de Anglais | LILACS | ID: biblio-899382

RÉSUMÉ

Objective: Schizophrenia is a chronic mental illness characterized by positive and negative symptoms. Cognitive impairment continues to be a core and consistent deficit. Previous studies have shown that physical activity (PA) is positively associated with cognitive performance. Thus, it may play a supportive role in mitigating cognitive impairments among individuals with schizophrenia. The aim of this study was to analyze the relationship between moderate-to-vigorous physical activity (MVPA) and executive function among adults with schizophrenia. Methods: The weekly amount of MVPA (assessed using accelerometers) and executive function (as per Brief Neurocognitive Assessment for Schizophrenia) of 78 adults with schizophrenia (mean [SD] age 42.4 [11.4] years; illness duration 17.0 [11.0] years; 58.2% male) were assessed in this cross-sectional study. Pearson correlations were calculated, followed by a linear regression. Participants were first analyzed together and then dichotomized on the basis of illness duration. Results: There was no significant association between MVPA and executive function, independent of the duration of illness. For individuals with < 15 years of illness, there was a significant association between weekly MVPA and working memory performance. Conclusion: PA appears to be associated with executive function in some, but not all, individuals with schizophrenia.


Sujet(s)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Jeune adulte , Schizophrénie/physiopathologie , Exercice physique/physiologie , Fonction exécutive/physiologie , Schizophrénie/traitement médicamenteux , Neuroleptiques/usage thérapeutique , Chlorpromazine/usage thérapeutique , Études transversales , Niveau d'instruction , Fonction exécutive/effets des médicaments et des substances chimiques , Tests neuropsychologiques
3.
Braz J Psychiatry ; 39(4): 309-315, 2017.
Article de Anglais | MEDLINE | ID: mdl-28380108

RÉSUMÉ

OBJECTIVE: Schizophrenia is a chronic mental illness characterized by positive and negative symptoms. Cognitive impairment continues to be a core and consistent deficit. Previous studies have shown that physical activity (PA) is positively associated with cognitive performance. Thus, it may play a supportive role in mitigating cognitive impairments among individuals with schizophrenia. The aim of this study was to analyze the relationship between moderate-to-vigorous physical activity (MVPA) and executive function among adults with schizophrenia. METHODS: The weekly amount of MVPA (assessed using accelerometers) and executive function (as per Brief Neurocognitive Assessment for Schizophrenia) of 78 adults with schizophrenia (mean [SD] age 42.4 [11.4] years; illness duration 17.0 [11.0] years; 58.2% male) were assessed in this cross-sectional study. Pearson correlations were calculated, followed by a linear regression. Participants were first analyzed together and then dichotomized on the basis of illness duration. RESULTS: There was no significant association between MVPA and executive function, independent of the duration of illness. For individuals with < 15 years of illness, there was a significant association between weekly MVPA and working memory performance. CONCLUSION: PA appears to be associated with executive function in some, but not all, individuals with schizophrenia.


Sujet(s)
Fonction exécutive/physiologie , Exercice physique/physiologie , Schizophrénie/physiopathologie , Adolescent , Adulte , Neuroleptiques/usage thérapeutique , Chlorpromazine/usage thérapeutique , Études transversales , Niveau d'instruction , Fonction exécutive/effets des médicaments et des substances chimiques , Femelle , Humains , Mâle , Adulte d'âge moyen , Tests neuropsychologiques , Schizophrénie/traitement médicamenteux , Jeune adulte
4.
J Pediatr ; 148(1): 62-7, 2006 Jan.
Article de Anglais | MEDLINE | ID: mdl-16423599

RÉSUMÉ

OBJECTIVE: To evaluate rectal sensitivity in patients with pediatric constipation (PC) and nonretentive fecal soiling (FNRFS) using pressure-controlled distention (barostat). STUDY DESIGN: Thresholds for rectal sensitivity (first sensation, urge to defecate, and pain), and rectal compliance were determined using a barostat. RESULTS: A total of 69 patients with PC (50 males; mean age, 10.9 +/- 2.2 years) and 19 patients with FNRFS (15 males; mean age, 10.0 +/- 1.9 years) were compared with 22 healthy volunteers (HVs) (11 males; mean age, 12.7 +/- 2.6 years). Sensitivity thresholds were not significantly different among the 3 groups. Rectal compliance was increased in 58% of the patients with PC (P < .0001 vs HVs). Rectal compliance did not differ between patients with FNRFS and HVs. Children with PC with abnormal rectal function required significantly larger rectal volumes at urge to defecate. CONCLUSIONS: Increased compliance is the most prominent feature in patients with PC. Because of higher compliance in these children, larger stool volumes are required to reach the intrarectal pressure of the urge to defecate. Children with FNRFS have normal rectal function.


Sujet(s)
Constipation/physiopathologie , Défécation/physiologie , Rectum/physiopathologie , Adolescent , Enfant , Compliance , Femelle , Humains , Mâle , Manométrie/instrumentation , Manométrie/méthodes , Sensation
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE